Parallel Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-124
| Closed | -$7.29K | – | 3448 |
|
|
2023
Q4 | $7.29K | Sell |
124
-2,182
| -95% | -$128K | ﹤0.01% | 2406 |
|
|
2023
Q3 | $100K | Buy |
2,306
+714
| +45% | +$31.1K | ﹤0.01% | 1083 |
|
|
2023
Q2 | $57.5K | Buy |
1,592
+179
| +13% | +$6.47K | ﹤0.01% | 1337 |
|
|
2023
Q1 | $52.5K | Sell |
1,413
-257
| -15% | -$9.56K | ﹤0.01% | 1355 |
|
|
2022
Q4 | $75.7K | Buy |
1,670
+546
| +49% | +$24.7K | ﹤0.01% | 1109 |
|
|
2022
Q3 | $79K | Buy |
1,124
+151
| +16% | +$10.6K | ﹤0.01% | 1063 |
|
|
2022
Q2 | $65K | Buy |
973
+602
| +162% | +$40.2K | ﹤0.01% | 1132 |
|
|
2022
Q1 | $31K | Buy |
371
+280
| +308% | +$23.4K | ﹤0.01% | 1516 |
|
|
2021
Q4 | $13K | Buy |
91
+65
| +250% | +$9.29K | ﹤0.01% | 2001 |
|
|
2021
Q3 | $5K | Buy |
26
+21
| +420% | +$4.04K | ﹤0.01% | 2382 |
|
|
2021
Q2 | $1K | Sell |
5
-18
| -78% | -$3.6K | ﹤0.01% | 2852 |
|
|
2021
Q1 | $4K | Buy |
23
+4
| +21% | +$696 | ﹤0.01% | 2288 |
|
|
2020
Q4 | $4K | Buy |
19
+13
| +217% | +$2.74K | ﹤0.01% | 2135 |
|
|
2020
Q3 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 2500 |
|